Literature DB >> 22659290

A caveolin-binding domain in the HCN4 channels mediates functional interaction with caveolin proteins.

Andrea Barbuti1, Angela Scavone, Nausicaa Mazzocchi, Benedetta Terragni, Mirko Baruscotti, Dario Difrancesco.   

Abstract

Pacemaker (HCN) channels have a key role in the generation and modulation of spontaneous activity of sinoatrial node myocytes. Previous work has shown that compartmentation of HCN4 pacemaker channels within caveolae regulates important functions, but the molecular mechanism responsible is still unknown. HCN channels have a conserved caveolin-binding domain (CBD) composed of three aromatic amino acids at the N-terminus; we sought to evaluate the role of this CBD in channel-protein interaction by mutational analysis. We generated two HCN4 mutants with a disrupted CBD (Y259S, F262V) and two with conservative mutations (Y259F, F262Y). In CHO cells expressing endogenous caveolin-1 (cav-1), alteration of the CBD shifted channels activation to more positive potentials, slowed deactivation and made Y259S and F262V mutants insensitive to cholesterol depletion-induced caveolar disorganization. CBD alteration also caused a significant decrease of current density, due to a weaker HCN4-cav-1 interaction and accumulation of cytoplasmic channels. These effects were absent in mutants with a preserved CBD. In caveolin-1-free fibroblasts, HCN4 trafficking was impaired and current density reduced with all constructs; the activation curve of F262V was not altered relative to wt, and that of Y259S displayed only half the shift than in CHO cells. The conserved CBD present in all HCN isoforms mediates their functional interaction with caveolins. The elucidation of the molecular details of HCN4-cav-1 interaction can provide novel information to understand the basis of cardiac phenotypes associated with some forms of caveolinopathies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659290     DOI: 10.1016/j.yjmcc.2012.05.013

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  25 in total

1.  Inhibition of cardiac pacemaker channel hHCN2 depends on intercalation of lipopolysaccharide into channel-containing membrane microdomains.

Authors:  Udo Klöckner; Uwe Rueckschloss; Claudia Grossmann; Saskia Matzat; Katja Schumann; Henning Ebelt; Ursula Müller-Werdan; Harald Loppnow; Karl Werdan; Michael Gekle
Journal:  J Physiol       Date:  2013-12-23       Impact factor: 5.182

2.  A novel mitochondrial Kv1.3-caveolin axis controls cell survival and apoptosis.

Authors:  Jesusa Capera; Mireia Pérez-Verdaguer; Roberta Peruzzo; María Navarro-Pérez; Juan Martínez-Pinna; Armando Alberola-Die; Andrés Morales; Luigi Leanza; Ildiko Szabó; Antonio Felipe
Journal:  Elife       Date:  2021-07-01       Impact factor: 8.140

Review 3.  New advances in the genetic basis of atrial fibrillation.

Authors:  Saagar Mahida; Patrick T Ellinor
Journal:  J Cardiovasc Electrophysiol       Date:  2012-10-15

4.  Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.

Authors:  Alexis Bosman; Laura Sartiani; Valentina Spinelli; Martina Del Lungo; Francesca Stillitano; Daniele Nosi; Alessandro Mugelli; Elisabetta Cerbai; Marisa Jaconi
Journal:  Stem Cells Dev       Date:  2013-02-27       Impact factor: 3.272

5.  Ca(2+)/calmodulin-activated phosphodiesterase 1A is highly expressed in rabbit cardiac sinoatrial nodal cells and regulates pacemaker function.

Authors:  Yevgeniya O Lukyanenko; Antoine Younes; Alexey E Lyashkov; Kirill V Tarasov; Daniel R Riordon; Joonho Lee; Syevda G Sirenko; Evgeny Kobrinsky; Bruce Ziman; Yelena S Tarasova; Magdalena Juhaszova; Steven J Sollott; David R Graham; Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2016-06-27       Impact factor: 5.000

6.  Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction.

Authors:  Shanshan Chen; Xiaojing Wang; Junhan Wang; Yuanyuan Zhao; Dan Wang; Chengcheng Tan; Jingjing Fa; Rongfeng Zhang; Fan Wang; Chaoping Xu; Yufeng Huang; Sisi Li; Dan Yin; Xin Xiong; Xiuchun Li; Qiuyun Chen; Xin Tu; Yanzong Yang; Yonglong Xia; Chengqi Xu; Qing K Wang
Journal:  Atherosclerosis       Date:  2016-01-08       Impact factor: 5.162

7.  Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice.

Authors:  Saagar Mahida
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30

8.  HCN4, Sinus Bradycardia and Atrial Fibrillation.

Authors:  Dario DiFrancesco
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-03-15

9.  Genetic variants associated with atrial fibrillationand long-term recurrence after catheter ablation for atrialfibrillation in Turkish patients.

Authors:  Taner Ulus; Muhammet Dural; Pelin Meşe; Furkan Yetmiş; Kadir Uğur Mert; Bülent Görenek; Oğuz Çilingir; Ebru Erzurumluoglu Gökalp; Serap Arslan; Sevilhan Artan; Özlem Aykaç; Ertuğrul Çolak; Hikmet Yorgun; Uğur Canpolat; Kudret Aytemir
Journal:  Anatol J Cardiol       Date:  2021-02       Impact factor: 1.596

10.  A detailed characterization of the hyperpolarization-activated "funny" current (If) in human-induced pluripotent stem cell (iPSC)-derived cardiomyocytes with pacemaker activity.

Authors:  Federica Giannetti; Patrizia Benzoni; Giulia Campostrini; Raffaella Milanesi; Annalisa Bucchi; Mirko Baruscotti; Patrizia Dell'Era; Alessandra Rossini; Andrea Barbuti
Journal:  Pflugers Arch       Date:  2021-05-02       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.